Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F K Mostofi

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
The Prostate|January 1, 1989
Crystalloids in latent prostatic carcinomaM Furusato, H Kato, H Takahashi, et al.
The Journal of Urology|September 1, 1996
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomyM C Bettencourt, J J Bauer, I A Sesterhenn, et al.
The Prostate. Supplement|January 11, 1992
Preliminary results of three-dimensional reconstruction of previously imaged prostatesI A Sesterhenn, F K Mostofi, R R Mattrey, et al.
The Prostate|June 15, 1997
Prostate-specific antigen-detected prostate cancer (stage T1c): an analysis of whole-mount prostatectomy specimensT H Douglas, D G McLeod, F K Mostofi, et al.
The Journal of Urology|August 1, 1997
Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumorsA Heidenreich, N S Schenkmann, I A Sesterhenn, et al.
JAMA|October 25, 1995
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American menJ W Moul, I A Sesterhenn, R R Connelly, et al.
Cancer|July 11, 1992
Report of the Committee on Staging and PathologyS D Graham, D G Bostwick, A Hoisaeter, et al.
Cancer|September 1, 1994
Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection ProjectC Mettlin, P J Littrup, R A Kane, et al.
The Journal of Urology|July 20, 1999
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patientsJ W Moul, R R Connelly, R M Mooneyhan, et al.
Surgery|August 1, 1996
Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancerJ W Moul, M C Bettencourt, I A Sesterhenn, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
The Prostate|January 1, 1989
Crystalloids in latent prostatic carcinomaM Furusato, H Kato, H Takahashi, et al.
The Journal of Urology|September 1, 1996
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomyM C Bettencourt, J J Bauer, I A Sesterhenn, et al.
The Prostate. Supplement|January 11, 1992
Preliminary results of three-dimensional reconstruction of previously imaged prostatesI A Sesterhenn, F K Mostofi, R R Mattrey, et al.
The Prostate|June 15, 1997
Prostate-specific antigen-detected prostate cancer (stage T1c): an analysis of whole-mount prostatectomy specimensT H Douglas, D G McLeod, F K Mostofi, et al.
The Journal of Urology|August 1, 1997
Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumorsA Heidenreich, N S Schenkmann, I A Sesterhenn, et al.
JAMA|October 25, 1995
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American menJ W Moul, I A Sesterhenn, R R Connelly, et al.
Cancer|July 11, 1992
Report of the Committee on Staging and PathologyS D Graham, D G Bostwick, A Hoisaeter, et al.
Cancer|September 1, 1994
Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection ProjectC Mettlin, P J Littrup, R A Kane, et al.
The Journal of Urology|July 20, 1999
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patientsJ W Moul, R R Connelly, R M Mooneyhan, et al.
Surgery|August 1, 1996
Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancerJ W Moul, M C Bettencourt, I A Sesterhenn, et al.
Pageof 14